NURECA · Healthcare · Medical Devices
Composite scorecard: 16/100 — Quality 33 · Valuation 0 · Momentum 1
| Share price | ₹282.46 |
| Market cap | ₹233 Cr |
| P/E ratio | 111.0 |
| P/B ratio | 1.2 |
| ROE | 2.1% |
| ROCE | 3.0% |
| Book value | ₹191.38 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹147 Cr | ₹2 Cr | 0.0% |
| 2025 | ₹110 Cr | ₹1 Cr | -7.0% |
| 2024 | ₹92 Cr | ₹-2 Cr | -11.0% |
| 2023 | ₹111 Cr | ₹-8 Cr | -13.0% |
| 2022 | ₹256 Cr | ₹45 Cr | 22.0% |
Nureca Limited provides home healthcare and wellness products in India. The company offers chronic disease products, such as nebulizers, blood pressure monitors, finger pulse oximeters, glucose meters, and thermometers, as well as connected products; orthopedic products, including massagers, pain management products, posture correctors, and rehabilitation products; and humidifiers and steamers, personal scales, yoga and exercise products, fitness tracking products, and dental and personal care products. It also provides mother and baby care products comprising baby feeding products, carry cots